(5.5 g) in HOAc (50 mL) was added and the resultant mixture
was refluxed for 8 h, after which the HOAc was removed
in vacuo leaving a brown residue that was partitioned between
CHCl3 and H2O (1 : 1, 600 mL). The organic layer was washed
twice with H2O, dried (MgSO4), and concentrated in vacuo to
give the crude product, which was chromatographed (Al2O3)
by elution with an EtOAc/C6H12 (1 : 1) solvent mixture.
Lastly, recrystallization (MeOH) gave pure 40-(3,5-diiodo-
7.98 [m, 4H, 4,40 0-tpy(7)H and 4,40 0-tpy(5)H], 7.45 [d, J = 5 Hz,
2H, 6,600-tpy(7)H], 7.37 [d, J = 5 Hz, 2H, 6,60 0-tpy(5)H],
7.32 [d, J = 8 Hz, 2H, 3,5-(5)ArH], 7.21-7.14 [m, 4H, 5,50 0-
tpy(7)H and 5,500-tpy(5)H], 3.97 [s, 3H, (5)ArOCH3]; 13C NMR
(CD3CN): d 163.22, 159.64, 159.44, 157.10, 156.54, 153.80,
149.61, 147.70, 146.03, 141.85, 139.46, 139.43, 137.43, 130.61,
130.17, 128.96, 128.77, 126.01, 125.88, 123.10, 122.32, 116.44,
96.78, 56.79; ESI-MS Calcd. 1291.9 (C43H30F12I2N6OP2Ru):
phenyl)-2,20 : 60,200-terpyridine (5), as
a
yellowish solid:
found: m/z 1146.9 (M–PF6)1+, 501.0 (M–2PF6)2+
.
1
1.33 g (34%); mp 230 1C; H NMR (CDCl3): d 8.76 (d, J =
4 Hz, 2H, 6,600-tpyH), 8.70 (d, J = 8 Hz, 2H, 3,30 0-tpyH),
8.64 (s, 2H, 30,50-tpyH), 8.17 (s, 2H, 2,6-ArH), 8.15 (s, 1H,
4-ArH), 7.93 (t, J = 6 Hz, 2H, 4,40 0-tpyH), 7.41 (t, J = 6 Hz,
2H, 5,50 0-tpyH); 13C NMR (CDCl3): d 156.00, 155.59, 149.03,
147.70, 145.74, 142.31, 137.67, 135.72, 124.46, 121.89, 119.12,
95.51; ESI-MS (560.92 calcd. for C21H13I2N3): m/z 561.9
(M+H)+.
Terpyridine-Ru(II) dimer (14)
To a degassed mixture of 13 (189 mg, 146 mmol), 1144,45
(94.1 mg, 366 mmol), Pd(PPh3)2Cl2 (7.1 mg,10 mmol), and
CuI (4.3 mg, 23 mmol) in a mixed solution of THF/MeCN
(50 mL, 20/30), (Me2CH)2NH (10 mL) was added. After
degassing five times with Argon, the mixture was stirred at
80 1C for 3 d. The solution was concentrated in vacuo to give a
red residue, which was chromatographed (Al2O3) by eluting
with a H2O/KNO3(conc.)/MeCN (1 : 1 : 10) solvent mixture to
afford terpyridine-Ru(II) dimer 14, which was treated with an
NH4PF6 MeOH solution in order to prepare the desired 14
(PF6ꢁ), as a light red solid: mp 4350 1C, 138 mg (61%);
1H NMR (CD3CN): d 9.19 [s, 2H, 30,50-tpy(7)H], 9.04 [s, 2H,
30,50-tpy(5)H], 8.86-8.70 [m, 15H, 3,30 0-tpy(7)H, 3,30 0-tpy(5)H,
3,300-tpy(11)H, 6,60 0-tpy(11)H, 30,50-tpy(11)H and 2,4,6-(7)ArH],
8.27-8.24 [m, 6H, 4,40 0-tpy(11)H and 2,6-(5)ArH], 8.07-7.99
[m, 2H, 4,40 0-tpy(5H and 4,400-tpy(7)H], 7.73 [t, J = 6 Hz, 4H,
5,500-tpy(11)H], 7.54 [d, J = 5 Hz, 2H, 6,60 0-tpy(7)H], 7.49 [d, J =
6 Hz, 2H, 6,60 0-tpy(5)H], 7.37 [d, J = 8 Hz, 2H, 3,5-(5)ArH],
7.30-7.23 [m, 4H, 5,500-tpy(7)H and 5,500-tpy(5)H], 4.03 [s, 3H,
(5)ArOCH3]; 13C NMR (CD3CN): d 163.24, 159.63, 159.42,
157.23, 156.53, 155.36, 154.12, 153.83, 149.68, 149.30, 146.77,
141.20, 139.55, 137.46, 134.64, 133.50, 130.63, 130.09, 129.11,
128.89, 126.99, 125.97, 125.35, 124.93, 123.40, 122.89, 122.31,
116.44, 94.10, 89.72, 56.84; ESI-MS Calcd.1550.3
(C77H50F12N12OP2Ru); found: m/z 1405.6 (M–PF6)1+, 630.6
40-(3,5-Diiodophenyl)-2,20 : 60,20 0-terpyridine-Ru(III) adduct (12)
Was prepared from a stirred solution of 40-(3,5-diiodophenyl)-
2,20 : 60,20 0-terpyridine (5; 77 mg, 137 mmol), RuCl3 (36.4 mg,
14 mmol) in MeOH (20 mL). After stirring at 25 1C for 1 h, the
mixture was refluxed for additional 8 h. After cooling to 25 1C,
the black precipitate was filtered and washed thoroughly with
MeOH and CHCl3 to give 40-(3,5-diiodophenyl)-2,20 : 60,200-
terpyridine-Ru(III) adduct 12, as a black solid (30 mg, 29%),
which was used directly.
40-(p-Methoxyphenyl)-2,20 : 60,200-terpyridine-Ru(III) adduct (8)
To a solution of RuCl3 (128 mg, 490 mmol) in MeOH (20 mL),
740 (157 mg, 463 mmol) was added. After being stirred
at 25 1C for 1 h, the solution was refluxed for 4 h to afford
40-(p-methoxy-phenyl)-2,20 :60,20 0-terpyridine-Ru(III) adduct 8, as
black solid (247 mg, 88%), which was used directly.
40-(3,5-Diiodophenyl)-2,20 :60,20 0-terpyridine-Ru(II)-40-(p-methoxy-
phenyl)-2,20 : 60,20 0-terpyridine h5-Ru(II)-7i (13)
(M–2PF6)2+
.
Method A. To a mixture of 5 (139 mg, 250 mmol) and 8
(137.5 mg, 250 mmol) in MeOH (50 mL), N-ethylmorpholine
(5 drops) was added. After stirring for 1 h at 25 1C, the mixture
was refluxed for additional 12 h. The solvent was evaporated
in vacuo to give a residue that was chromatographed (SiO2) by
eluting with a H2O/KNO3 (conc.)/MeCN (1 : 1 : 10) solvent
mixture to afford h5-Ru(II)-7i (13), which was treated with
methanolic NH4PF6 in order to prepare the desired 13 (PF6ꢁ),
as a dark red solid (271 mg, 84%), which was identical in all
respects to the sample derived from Method B.
Heteronuclear-Fe(II)Ru(II) hexameric macrocycle 15
A mixture of bisterpyridine ligand 14 (30 mg, 19 mmol) and
FeCl2 (3.8 mg, 1 eq.) in MeOH (30 mL) was refluxed for 12 h.
After the solvent was removed in vacuo, the residue was
chromatographed (SiO2) by eluting with
a H2O/KNO3
(conc.)/MeCN (1 : 1 : 10) solvent mixture. After removal of
the solvent in vacuo, the residue was washed with water,
dissolved in MeOH, and excess methanolic NH4PF6 was
added to precipitate the complex. The collected dark purple
solid was washed thoroughly with MeOH to afford the desired
hexameric macrocycle 15, as purple solid: 10.2 mg (36%);
1H NMR (CD3CN): d 9.25-9.20 [m, 36H, 30,50-tpy(Fe)H
and 30,50-tpy(7)H], 9.03 [s, 12H, 30,50-tpy(5)H], 8.85 [m, 24H,
3,30 0-tpy(Fe)H], 8.81 [s, 6H, 4-(7)ArH], 8.71 [d, J = 5 Hz, 12H,
3,30 0-tpy(7)H], 8.65 [m, 24H, 3,30 0-tpy(5)H and 2, 6-(7)ArH],
8.24 [d, J = 5 Hz, 12H, 2,6-(5)ArH], 7.99 [m, 48H, 4,40 0-tpy(5)H,
4,400-tpy(7)H, and 4,40 0-tpy(Fe)H], 7.55 [m, 36H, 6,60 0-tpy(Fe)H
and 3,5-(5)ArH] 7.34-7.17 [m, 72H, 6,60 0-tpy(7)H, 6,60 0-tpy(5)H,
5,500-tpy(7)H, 5,50 0-tpy(5)H, and 5,50 0-tpy(Fe)H], 3.99 [s, 18H,
(5)ArOCH3]; 13C NMR (CD3CN): d 162.95, 161.51, 159.41,
Method B. To a mixture of 12 (16 mg, 20 mmol) and 7 (7 mg,
20 mmol) in MeOH (10 mL), 2 drops of N-ethylmorpholine
was added. After refluxing for 12 h, the solution was concen-
trated in vacuo and the residue was chromatographed (SiO2)
by eluting with a H2O/KNO3(conc.)/MeCN (1 : 1 : 10) solvent
mixture to afford h5-Ru(II)-7i (13), which was treated with
methanolic NH4PF6 in order to prepare the desired 13 (PF6ꢁ),
as a dark red solid: 19.9 mg (77%); 1H NMR (CD3CN): d 8.98
[s, 2H, 30,50-tpy(7)H], 8.96 [s, 2H, 30,50-tpy(5)H], 8.65 [brd, 4H,
3,30 0-tpy(7)H and 3,30 0-tpy(5)H], 8.59 [s, 2H, 2,6-(7)ArH],
8.42 [s, 1H, 4-(7)ArH], 8.21 [d, J = 9 Hz, 2H, 2,6-(5)ArH],
c
2134 New J. Chem., 2011, 35, 2130–2135
This journal is The Royal Society of Chemistry and the Centre National de la Recherche Scientifique 2011